CHICAGO, Dec. 14 /PRNewswire/ -- Today the British Midlands Development Corporation announced that Nebraska based GeneSeek has chosen the British Midlands as the location for their new European operation.
GeneSeek will be setting up their new base of operations in BioCity Nottingham, the UK’s largest bioscience and healthcare innovation center. BioCity provides state-of-the-art laboratories, equipment, and office space for bioscience start-up companies and has the perfect infrastructure for GeneSeek to establish its presence in the European market.
“European expansion is an important component of GeneSeek’s growth strategy which also includes new laboratory and offices in India to address the Asian market,” said Abe Oommen, President and CEO of GeneSeek, “By selecting BioCity Nottingham as the location for our European operations, we’ll be able to leverage the region’s skill base, well-established science industry, and access all of our key markets.”
“We’ve worked closely with the investment team at the British Midlands as well as BioCity to make this project happen,” said Oommen, “GeneSeek is ready to take on the opportunities in these new markets and launch the next phase of the company’s growth.”
“GeneSeek and its research and development operations are well suited for the British Midlands,” said Vern Sebby, President and CEO of British Midlands Development Corporation, “We have 17-world class universities with UK leading research in genomics and clinical diagnostics, as well as one the strongest science industry clusters in Europe.”
“We’re thrilled that GeneSeek chose the Midlands,” continued Sebby, “We look forward to continuing our support and sharing regional expertise with them as the company’s European operations grow.”
About GeneSeek
GeneSeek provides comprehensive research and product development solutions for the Life Science, Agribusiness, Pharmaceutical and Biotechnology industries. We provide customers with a full range of solutions, from basic research to high throughput genomic screening for predictive and causative mutations, clinical diagnostics systems and devices, and therapeutic protein production and discovery.
GeneSeek enables development, testing and pilot production under one roof for products ranging from diagnostic SNP panels to biologics for use in agriculture, pharmacogenomics, clinical diagnostics and health care. GeneSeek has developed unique expertise and capabilities that knit together several related fields into one integrated system that incorporates information technology and instrumentation for providing comprehensive high throughput solutions for our clients. For more information, please visit www.geneseek.com
About British Midlands Development Corporation
The British Midlands Development Corporation is the North American economic development agency for central England. The Midlands region is located just one hour to the north of London and includes the major commercial centers of Birmingham, Nottingham, Coventry and Northampton.
As an agency funded by the UK Government, The British Midlands Development Corporation provides specialist advice and support to North American companies seeking to establish a presence or expand a current operation in the region. The British Midlands Development Corporation provides access to business networks, details about sources for grants and funding, business support services, and information to help companies identify opportunities to develop and grow.
The British Midlands Development Corporation is based in Chicago with branch offices in Boston, Washington, DC and San Jose.
www.thebritishmidlands.comshirar@thepontgroup.com
CONTACT: Shirar O’Connor-Mugler of the Pont Group, +1-646-496-7668,
shirar@thepontgroup.com, for British Midlands Development Corporation
Web site: http://www.thebritishmidlands.com/
http://www.geneseek.com/
